tiprankstipranks
Trending News
More News >
Harvard Bioscience (HBIO)
NASDAQ:HBIO
US Market

Harvard Bioscience (HBIO) Income Statement

Compare
192 Followers

Harvard Bioscience Income Statement

Last quarter (Q4 2024), Harvard Bioscience's total revenue was $24.56M, a decrease of -12.78% from the same quarter last year. In Q4, Harvard Bioscience's net income was $18.00K. See Harvard Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 94.14M$ 112.25M$ 113.33M$ 118.90M$ 102.10M
Gross Profit
$ 54.77M$ 66.07M$ 60.82M$ 67.65M$ 58.04M
Operating Expenses
$ 60.98M$ 64.18M$ 67.98M$ 65.59M$ 57.82M
Depreciation and Amortization
$ 7.16M$ 7.00M$ 7.58M$ 7.62M$ 7.63M
EBITDA
$ -1.30M$ 8.03M$ 944.00K$ 11.31M$ 5.49M
Operating Income
$ -6.21M$ 1.89M$ -7.17M$ 1.40M$ -585.00K
Other Income/Expenses
$ -5.45M$ -4.45M$ -2.25M$ -2.21M$ -7.51M
Pretax Income
$ -11.66M$ -2.56M$ -9.18M$ -140.00K$ -7.29M
Net Income
$ -12.40M$ -3.42M$ -9.52M$ -288.00K$ -7.81M
Per Share Metrics
Basic EPS
$ -0.28$ -0.08$ -0.23$ -0.01$ -0.20
Diluted EPS
$ -0.28$ -0.08$ -0.23$ -0.01$ -0.20
Weighted Average Shares Outstanding
43.54M 42.42M 41.41M 40.34M 38.64M
Weighted Average Shares Outstanding (Diluted)
43.54M 42.42M 41.41M 40.34M 38.64M
Currency in USD

Harvard Bioscience Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis